Study Summary
This trial is testing whether restrictive transfusions (at Hb<7g/dL) are as effective as liberal transfusions (at Hb<9g/dL) in reducing fatigue and improving activity levels in hospitalized patients with anemia.
- Anemia
- Fatigue
- Physical Function
- Blood Transfusion
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 3 Secondary · Reporting Duration: Fatigue will be measured at admission to the hospital during the index hospitalization and 7 days after hospital discharge.
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Restrictive Transfusion Arm
1 of 2
Liberal Transfusion Arm
1 of 2
Active Control
748 Total Participants · 2 Treatment Groups
Primary Treatment: Restrictive Transfusion Arm · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is this experiment searching for new participants at present?
"Affirmative. Data on clinicaltrials.gov affirms that this study, which was first publicized in February of 2022, is still actively searching for participants. There are 748 available slots at a single medical facility." - Anonymous Online Contributor
What is the overall participation rate for this experiment?
"Affirmative. The online record on clinicaltrials.gov confirms that this research has been luring participants since February 1st 2022 and was most recently updated May 16th 2022. Altogether, 748 subjects are expected to join the study from a single trial centre." - Anonymous Online Contributor